Met and its ligand HGF are associated with clinical outcome in breast cancer

Few biomarkers exist to predict radiotherapy response in breast cancer. In vitro studies suggest a role for Met and its ligand HGF. To study this suggested role, MET and HGF gene copy numbers were determined by droplet digital PCR in tumours from 205 pre-menopausal and 184 post-menopausal patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Veenstra, Cynthia, Pérez-Tenorio, Gizeh, Stelling, Anna, Karlsson, Elin, Mirwani, Sanam Mirwani, Nordensköljd, Bo, Fornander, Tommy, Stål, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095065/
https://www.ncbi.nlm.nih.gov/pubmed/27175600
http://dx.doi.org/10.18632/oncotarget.9268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095065/
https://www.ncbi.nlm.nih.gov/pubmed/27175600
http://dx.doi.org/10.18632/oncotarget.9268

Ejemplares similares